ONCOLOGIC
DRUGS ADVISORY COMMITTEE
Food and Drug Administration
CENTER FOR DRUG EVALUATION AND RESEARCH
Donna Przepiorka, M.D.,
Ph.D.
Expertise: Hematology, Bone Marrow
Transplantation
Term:
Professor of Medicine
Department of Hematology/Oncology
Advisors &
Consultants Staff, HFD-21
Food and Drug
Administration
(301)
827-7001 FAX (301) 827-6776
CliffordJ@cder.fda.gov
Birmingham,
Alabama 35294-3280
Bruce G. Redman, D.O.
Expertise: Clinical Oncology,
Hematology
Division of Hematology/Oncology
7216
Ann Arbor,
Michigan 48109-0948
Sarah A.
Taylor, M.D.
Expertise: General Oncology &
Palliative Care Term:
Otis W. Brawley, M.D.
Expertise: Oncology/Hematology
Term:
Associate
Director for Cancer Control
Winship
Cancer Institute
Professor
of Hematology, Oncology, Medicine &
Epidemiology
Professor of Biostatistics
Department of Biostatistics and
Bioinformatics
Head
of Hematology
Head,
Medical Oncology- Breast Cancer Section
John
Wayne Cancer Institute -
2001 Santa Monica Blvd, Suite 860W
Santa Monica, California 90404
Chairman, Children’s Oncology Group
Professor of Pediatrics
The
Division of Hematology - Oncology
Children’s
James H. Doroshow, M.D.
Expertise: Medical Oncology
Term:
Chairman, Department of Medical Oncology
and Therapeutics Research
City
of
*Pamela J. Haylock, RN
Expertise: Oncology
Term:
Oncology Consultant
Medina,
Texas 78055
Alexandra M.
Levine, M.D
Expertise: Medical Oncology
Term:
Medical Director
USC/
Division of Hematology MS34
Maria
Rodriguez, M.D.
Expertise: Lymphoma/Myeloma
Term:
Chairman,
Ad-Interim
Department
of Lymphoma/Myeloma
1515
Holcombe,
* Consumer Representative